NCT01133938
Completed
Not Applicable
Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies
Orthopedic Hospital Vienna Speising1 site in 1 country79 target enrollmentJanuary 2009
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Predictors of Osteonecrosis of the Femoral Head After Treatment of the Dislocated Hip
- Sponsor
- Orthopedic Hospital Vienna Speising
- Enrollment
- 79
- Locations
- 1
- Primary Endpoint
- Osteonecrosis of the femoral head
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
Several risk factors for the development of osteonecrosis of the femoral head following treatment of developmental dislocated hip have been reported. The need for further research with a large-enough sample size including statistical adjustment of confounders was demanded. The purpose of the present study was to find reliable predictors of osteonecrosis in patients managed for developmental dislocation of the hip and to evaluate if delayed treatment increased the risk of residual acetabular dysplasia requiring secondary surgeries.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Follow-up \> 3 years
Exclusion Criteria
- •teratological hip dislocation
- •neuromuscular disease
- •previous open reduction at another medical institution
Outcomes
Primary Outcomes
Osteonecrosis of the femoral head
Secondary Outcomes
- Secondary reconstructive procedures due to residual acetabular dysplasia
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Determination of risk factors for developing osteoporosis in COPD GOLD II patients. A case control study to identify possible risk factors for developing osteoporosis in COPD GOLD II patients.bone decalcification. AND chronic bronchitisemfysemaOsteoporosis1000595910006436NL-OMON31334Catharina-ziekenhuis100
Recruiting
Not Applicable
Prospective study to the pathogenesis of osteoporosis in patients with indolent systemic mastocytosisHealthy volunteersM80D47Osteoporosis with pathological fractureOther neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissueDRKS00030069MVZ-Endokrinologikum60
Completed
Phase 2
Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral HeadAvascular Necrosis of Femur HeadNCT02890537Erasme University Hospital82
Completed
Phase 3
Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral HeadOsteonecrosisNCT01892514Istituto Ortopedico Rizzoli104
Unknown
Not Applicable
Risk factors of osteonecrosis of the jaw in patients with multiple myeloma receiving IV bisphosphonatesPatients diagnosed with multiple myeloma and had received intravenous bisphosphonates.Risk factor, Multiple myeloma, Intravenous bisphosphonateTCTR20230206007Chulalongkorn University120